AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense
Apr 4 04:12
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Apr 3 05:08
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director Quaggin Susan E
Apr 3 05:08
AbbVie | 4: Statement of changes in beneficial ownership of securities-Director RAPP EDWARD J
Apr 3 05:07
AbbVie | PX14A6G: Notice of exempt solicitation
Apr 3 04:09
AbbVie | PX14A6G: Notice of exempt solicitation
Mar 27 02:35
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Donoghoe Nicholas
Mar 23 05:03
AbbVie | 144/A: Others
Mar 22 02:32
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 21 07:33
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Stewart Jeffrey Ryan
Mar 21 05:03
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 19 05:07
AbbVie | ARS: Annual Report to Security Holders
Mar 19 04:30
AbbVie | DEF 14A: Definitive information statements
Mar 19 04:23
AbbVie | DEFA14A: Others
Mar 19 04:22
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer RICHMOND TIMOTHY J.
Mar 6 06:34
AbbVie | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 5 06:25
AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 2 08:55
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Reents Scott T
Mar 2 06:55
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Buckbee Kevin K
Mar 2 06:55
AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Michael Robert A.
Mar 2 06:55
No Data
No Data